公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2018 | Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study | CHIA-CHI LIN ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHAO-CHI HO ; WEI-YU LIAO ; JIH-HSIANG LEE ; TZU-HSIU TSAI ; KANG-YI SU ; MIN-SHU HSIEH ; YIH-LEONG CHANG ; Bai Y.-Y.; DE-RUI HUANG ; Thress K.S.; CHIH-HSIN YANG | The Lancet Respiratory Medicine | 120 | 109 | |
2022 | PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients | Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; KANG-YI SU ; SUNG-LIANG YU ; Chen, Jeremy J W; Huang, Yen-Hsiang; Chang, Gee-Chen | Scientific reports | 11 | 9 | |
2019 | Perinatal polychlorinated biphenyls and polychlorinated dibenzofurans exposure are associated with DNA methylation changes lasting to early adulthood: Findings from Yucheng second generation | KANG-YI SU ; Li M.-C.; Lee N.-W.; Ho B.-C.; Cheng C.-L.; Chuang Y.-C.; SUNG-LIANG YU ; Yue Leon Guo | Environmental Research | 17 | 15 | |
2013 | Potential therapeutic role of hispidulin in gastric cancer through induction of apoptosis via NAG-1 signaling | Yu C.Y.; KANG-YI SU ; Lee P.-L.; Jhan J.-Y.; Tsao P.-H.; Chan D.-C.; Chen Y.-L.S. | Evidence-based Complementary and Alternative Medicine | 35 | 31 | |
2012 | Potential therapeutic role of Z-isochaihulactone in lung cancer through induction of apoptosis via notch signaling | Ou J.-P.; Lin H.-Y.; KANG-YI SU ; SUNG-LIANG YU ; Tseng I.-H.; Chen C.-J.; Hsu H.-C.; Chan D.-C.; Sophia Chen Y.-L. | Evidence-based Complementary and Alternative Medicine | 15 | 13 | |
2016 | Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patients | Huang Y.-H.; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; KANG-YI SU ; Chen H.-Y.; Chang C.-S.; Chen J.J.W.; SUNG-LIANG YU ; HUEI-WEN CHEN ; Yang T.-Y.; Chang G.-C. | Journal of Thoracic Disease | 2 | 2 | |
2012 | Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer | KANG-YI SU ; Chen H.-Y.; Li K.-C.; Kuo M.-L.; CHIH-HSIN YANG ; Chan W.-K.; Ho B.-C.; Chang G.-C.; JIN-YUAN SHIH ; SUNG-LIANG YU ; PAN-CHYR YANG | Journal of Clinical Oncology | 464 | 428 | |
2021 | Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment | Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Zheng, Zhe-Rong; Yang, Tsung-Ying; Chen, Kun-Chieh; Huang, Yen-Hsiang; KANG-YI SU ; SUNG-LIANG YU ; Chang, Gee-Chen | Oncology | 9 | 9 | |
2014 | Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma | Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; CHONG-JEN YU ; WEI-YU LIAO ; Tsai, Chi-Ren; Tsai, Meen-Hsin; SUNG-LIANG YU ; KANG-YI SU ; Chen, Jeremy Jw; Chen, Hsuan-Yu; MONG-HSUN TSAI | OncoTargets and Therapy | 15 | 14 | |
2021 | Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan | SHANG-GIN WU ; WEI-YU LIAO ; KANG-YI SU ; SUNG-LIANG YU ; YEN-LIN HUANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; JIN-YUAN SHIH | JTO Clinical and Research Reports | 16 | 0 | |
2018 | Proofreading and DNA repair assay using single nucleotide extension and MALDI-TOF mass spectrometry analysis | KANG-YI SU ; Goodman S.D.; Lai H.-M.; Yen R.-S.; Hu W.-Y.; WERN-CHERNG CHENG ; LIANG-IN LIN ; YA-CHIEN YANG ; WOEI-HORNG FANG | Journal of Visualized Experiments | 4 | 4 | |
2020 | Proofreading of single nucleotide insertion/deletion replication errors analyzed by MALDI-TOF mass spectrometry assay | Chang, Hui Lan; KANG-YI SU ; Goodman, Steven D.; Chou, Neng An; Lin, Kuei Ching; WERN-CHERNG CHENG ; LIANG-IN LIN ; SUI-YUAN CHANG ; WOEI-HORNG FANG | DNA Repair | 1 | 1 | |
2020 | Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression | Chen, Yi-Ju; Roumeliotis, Theodoros I; Chang, Ya-Hsuan; Chen, Ching-Tai; Han, Chia-Li; MIAO-HSIA LIN ; HUEI-WEN CHEN ; Chang, Gee-Chen; YIH-LEONG CHANG ; CHEN-TU WU ; MONG-WEI LIN ; MIN-SHU HSIEH ; Wang, Yu-Tai; Chen, Yet-Ran; Jonassen, Inge; Ghavidel, Fatemeh Zamanzad; Lin, Ze-Shiang; Lin, Kuen-Tyng; Chen, Ching-Wen; Sheu, Pei-Yuan; Hung, Chen-Ting; Huang, Ke-Chieh; Yang, Hao-Chin; Lin, Pei-Yi; Yen, Ta-Chi; Lin, Yi-Wei; Wang, Jen-Hung; Raghav, Lovely; Lin, Chien-Yu; Chen, Yan-Si; Wu, Pei-Shan; Lai, Chi-Ting; Weng, Shao-Hsing; KANG-YI SU ; Chang, Wei-Hung; Tsai, Pang-Yan; Robles, Ana I; Rodriguez, Henry; Hsiao, Yi-Jing; Chang, Wen-Hsin; Sung, Ting-Yi; JIN-SHING CHEN ; SUNG-LIANG YU ; Choudhary, Jyoti S; Chen, Hsuan-Yu; PAN-CHYR YANG ; Chen, Yu-Ju | Cell | 154 | 134 | |
2021 | Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M | Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; KANG-YI SU ; SUNG-LIANG YU ; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen | Scientific reports | 0 | 0 | |
2012 | R26R-GR: A Cre-Activable Dual Fluorescent Protein Reporter Mouse | YOU-TZUNG CHEN ; Tsai M.-S.; TSUNG-LIN YANG ; Ku A.T.; Huang K.-H.; Huang C.-Y.; Chou F.-J.; Fan H.-H.; JIN-BON HONG ; Yen S.-T.; Wang W.-L.; Lin C.-C.; Hsu Y.-C.; KANG-YI SU ; Su I.-C.; Jang C.-W.; Behringer R.R.; Favaro R.; Nicolis S.K.; CHUNG-LIANG CHIEN ; SHU-WHA LIN ; Yu I.-S. | PLoS ONE | 13 | 10 | |
2015 | R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability | Chen H.-Y.; SUNG-LIANG YU ; Ho B.-C.; KANG-YI SU ; Hsu Y.-C.; Chang C.-S.; Li Y.-C.; Yang S.-Y.; Hsu P.-Y.; Ho H.; Chang Y.-H.; Chen C.-Y.; Yang H.-I.; Hsu C.-P.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Hsia J.-Y.; Chuang C.-Y.; Yuan S.; Lee M.-H.; Liu C.-H.; Wu G.-I.; Hsiung C.A.; Chen Y.-M.; Wang C.-L.; Huang M.-S.; CHONG-JEN YU ; KUAN-YU CHEN ; Tsai Y.-H.; Su W.-C.; HUEI-WEN CHEN ; Chen J.J.W.; Chen C.-J.; Chang G.-C.; PAN-CHYR YANG ; Li K.-C. | Journal of Clinical Oncology | 76 | 71 | |
2017 | Rapid Sputum Multiplex Detection of the M. tuberculosis Complex (MTBC) and Resistance Mutations for Eight Antibiotics by Nucleotide MALDI-TOF MS | KANG-YI SU ; BO-SHIUN YAN ; HAO-CHIEH CHIU ; CHONG-JEN YU ; Chang S.-Y.; Jou R.; Liu J.-L.; PO-REN HSUEH ; SUNG-LIANG YU | Scientific Reports | 16 | 10 | |
2012 | RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer | TZU-HSIU TSAI ; KANG-YI SU ; SHANG-GIN WU ; YIH-LEONG CHANG ; Luo S.-C.; Jane I.-S.; CHONG-JEN YU ; Yue S.-L.; JIN-YUAN SHIH ; PAN-CHYR YANG | European Respiratory Journal | 42 | 37 | |
2014 | Rutin, a flavonoid and principal component of Saussurea involucrata, attenuates physical fatigue in a forced swimming mouse model | KANG-YI SU ; Yu C.Y.; Chen Y.-W.; Huang Y.-T.; Chen C.-T.; Wu H.-F.; Sophia Chen Y.-L. | International Journal of Medical Sciences | 71 | 68 | |
2012 | Rutin, a flavonoid that is a main component of Saussurea involucrata, attenuates the senescence effect in D-galactose aging mouse model | Yang Y.-C.; Lin H.-Y.; KANG-YI SU ; Chen C.-H.; Yu Y.-L.; Lin C.-C.; SUNG-LIANG YU ; Yan H.-Y.; Su K.-J.; Chen Y.-L.S. | Evidence-based Complementary and Alternative Medicine | 44 | 33 | |